Abstract
Decades of experimental work have established an imbalance of excitation and inhibition as the leading mechanism of the transition from normal brain function to seizure. In epilepsy, these transitions are rare and abrupt. Transition processes incorporating positive feedback, such as activity-dependent disinhibition, could provide these uncommon timing features. A rapidly expanding array of genetic etiologies will help delineate the molecular mechanism(s). This delineation will entail quite a bit of cell biology. The genes discovered so far are more remarkable for their diversity than their similarities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Matsumoto, H. & Ajmonemarsan, C. Cellular mechanisms in experimental epileptic seizures. Science 144, 193–194 (1964).
Prince, D.A. & Wilder, B.J. Control mechanisms in cortical epileptogenic foci. “Surround” inhibition. Arch. Neurol. 16, 194–202 (1967).
Walther, H., Lambert, J.D., Jones, R.S., Heinemann, U. & Hamon, B. Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium. Neurosci. Lett. 69, 156–161 (1986).
Wiechert, P. & Herbst, A. Provocation of cerebral seizures by derangement of the natural balance between glutamic acid and γ-aminobutyric acid. J. Neurochem. 13, 59–64 (1966).
Croucher, M.J., Collins, J.F. & Meldrum, B.S. Anticonvulsant action of excitatory amino acid antagonists. Science 216, 899–901 (1982).
Scharfman, H.E. The neurobiology of epilepsy. Curr. Neurol. Neurosci. Rep. 7, 348–354 (2007).
Jett, D.A. Chemical toxins that cause seizures. Neurotoxicology 33, 1473–1475 (2012).
Boison, D. Methylxanthines, seizures, and excitotoxicity. Handb. Exp. Pharmacol. 200, 251–266 (2011).
Moran, N.F. et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1,652 people with epilepsy. Seizure 13, 425–433 (2004).
Macdonald, R.L. & Kang, J.Q. mRNA surveillance and endoplasmic reticulum quality control processes alter biogenesis of mutant GABAA receptor subunits associated with genetic epilepsies. Epilepsia 53 (suppl. 9), 59–70 (2012).
Yu, F.H. et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9, 1142–1149 (2006).
Carvill, G.L. et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology 82, 1245–1253 (2014).
Ran, X. et al. EpilepsyGene: a genetic resource for genes and mutations related to epilepsy. Nucleic Acids Res. doi:10.1093/nar/gku943 (2014).
Epi4K Consortium & Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature 501, 217–221 (2013).
Veeramah, K.R. et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia 54, 1270–1281 (2013).
Weckhuysen, S. et al. KCNQ2 Study Group. Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients. Neurology 81, 1697–1703 (2013).
Zhang, W. et al. Surviving hilar somatostatin interneurons enlarge, sprout axons, and form new synapses with granule cells in a mouse model of temporal lobe epilepsy. J. Neurosci. 29, 14247–14256 (2009).
Buckmaster, P.S. Does mossy fiber sprouting give rise to the epileptic state? Adv. Exp. Med. Biol. 813, 161–168 (2014).
Sutula, T.P. & Dudek, F.E. Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: an emergent property of a complex system. Prog. Brain Res. 163, 541–563 (2007).
Ferini-Strambi, L., Sansoni, V. & Combi, R. Nocturnal frontal lobe epilepsy and the acetylcholine receptor. Neurologist 18, 343–349 (2012).
Herzog, A.G. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure 17, 151–159 (2008).
Lopes da Silva, F. et al. Epilepsies as dynamical diseases of brain systems: basic models of the transition between normal and epileptic activity. Epilepsia 44 (suppl. 12), 72–83 (2003).
Jirsa, V.K., Stacey, W.C., Quilichini, P.P., Ivanov, A.I. & Bernard, C. On the nature of seizure dynamics. Brain 137, 2210–2230 (2014).
Bracci, E., Vreugdenhil, M., Hack, S.P. & Jefferys, J.G. Dynamic modulation of excitation and inhibition during stimulation at gamma and beta frequencies in the CA1 hippocampal region. J. Neurophysiol. 85, 2412–2422 (2001).
Patenaude, C., Massicotte, G. & Lacaille, J.C. Cell-type specific GABA synaptic transmission and activity-dependent plasticity in rat hippocampal stratum radiatum interneurons. Eur. J. Neurosci. 22, 179–188 (2005).
Wester, J.C. & McBain, C.J. Behavioral state-dependent modulation of distinct interneuron subtypes and consequences for circuit function. Curr. Opin. Neurobiol. 29C, 118–125 (2014).
Morimoto, K., Fahnestock, M. & Racine, R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73, 1–60 (2004).
Valentine, M., Keddie, K.M. & Dunne, D. A comparison of techniques in electro-convulsive therapy. Br. J. Psychiatry 114, 989–996 (1968).
Le Duigou, C., Holden, T. & Kullmann, D.M. Short- and long-term depression at glutamatergic synapses on hippocampal interneurons by group I mGluR activation. Neuropharmacology 60, 748–756 (2011).
Jane, D.E., Lodge, D. & Collingridge, G.L. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 56, 90–113 (2009).
Méndez, P. & Bacci, A. Assortment of GABAergic plasticity in the cortical interneuron melting pot. Neural Plast. 2011, 976856 (2011).
Kaeser, P.S. & Regehr, W.G. Molecular mechanisms for synchronous, asynchronous, and spontaneous neurotransmitter release. Annu. Rev. Physiol. 76, 333–363 (2014).
Rajakulendran, S., Kaski, D. & Hanna, M.G. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat. Rev. Neurol. 8, 86–96 (2012).
Lazarevic, V., Pothula, S., Andres-Alonso, M. & Fejtova, A. Molecular mechanisms driving homeostatic plasticity of neurotransmitter release. Front. Cell. Neurosci. 7, 244 (2013).
Casillas-Espinosa, P.M., Powell, K.L. & O'Brien, T.J. Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy. Epilepsia 53 (suppl. 9), 41–58 (2012).
Meier, J.C., Semtner, M., Winkelmann, A. & Wolfart, J. Presynaptic mechanisms of neuronal plasticity and their role in epilepsy. Front. Cell. Neurosci. 8, 164 (2014).
Letts, V.A. et al. The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat. Genet. 19, 340–347 (1998).
Yokoi, N., Fukata, M. & Fukata, Y. Synaptic plasticity regulated by protein-protein interactions and posttranslational modifications. Int. Rev. Cell Mol. Biol. 297, 1–43 (2012).
Fukata, Y. et al. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313, 1792–1795 (2006).
Goodkin, H.P., Joshi, S., Mtchedlishvili, Z., Brar, J. & Kapur, J. Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J. Neurosci. 28, 2527–2538 (2008).
Naylor, D.E., Liu, H., Niquet, J. & Wasterlain, C.G. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol. Dis. 54, 225–238 (2013).
Kovács, R. et al. Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices. J. Neurosci. 29, 8565–8577 (2009).
Chang, P., Walker, M.C. & Williams, R.S. Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid. Neurobiol. Dis. 62, 296–306 (2014).
Fisher, R.S., Pedley, T.A., Moody, W.J. Jr. & Prince, D.A. The role of extracellular potassium in hippocampal epilepsy. Arch. Neurol. 33, 76–83 (1976).
Staley, K.J., Soldo, B.L. & Proctor, W.R. Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269, 977–981 (1995).
Ransom, C.B., Ransom, B.R. & Sontheimer, H. Activity-dependent extracellular K+ accumulation in rat optic nerve: the role of glial and axonal Na+ pumps. J. Physiol. (Lond.) 522, 427–442 (2000).
Raimondo, J.V. et al. A genetically-encoded chloride and pH sensor for dissociating ion dynamics in the nervous system. Front. Cell. Neurosci. 7, 202 (2013).
Deng, H., Xiu, X. & Song, Z. The molecular biology of genetic-based epilepsies. Mol. Neurobiol. 49, 352–367 (2014).
Heinemann, U., Konnerth, A., Pumain, R. & Wadman, W.J. Extracellular calcium and potassium concentration changes in chronic epileptic brain tissue. Adv. Neurol. 44, 641–661 (1986).
Kovács, R., Kardos, J., Heinemann, U. & Kann, O. Mitochondrial calcium ion and membrane potential transients follow the pattern of epileptiform discharges in hippocampal slice cultures. J. Neurosci. 25, 4260–4269 (2005).
Macdonald, R.L. & Botzlakis, E.J. in Physiology and Pathology of Chloride Transporters and Channels in the Nervous System (eds. Alvarez-Leefmans, F. & Delpire, E.) Ch. 14, 257–282 (Elsevier, London, 2009).
Staley, K.J. & Proctor, W.R. Modulation of mammalian dendritic GABA(A) receptor function by the kinetics of Cl− and HCO3− transport. J. Physiol. (Lond.) 519, 693–712 (1999).
Kahle, K.T. et al. Roles of the cation-chloride cotransporters in neurological disease. Nat. Clin. Pract. Neurol. 4, 490–503 (2008).
Larsen, B.R. et al. Contributions of the Na+/K+-ATPase, NKCC1, and Kir4.1 to hippocampal K+ clearance and volume responses. Glia 62, 608–622 (2014).
Lillis, K.P., Kramer, M.A., Mertz, J., Staley, K.J. & White, J.A. Pyramidal cells accumulate chloride at seizure onset. Neurobiol. Dis. 47, 358–366 (2012).
Albensi, B.C., Oliver, D.R., Toupin, J. & Odero, G. Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: are they effective or relevant? Exp. Neurol. 204, 1–13 (2007).
Bertram, E. The relevance of kindling for human epilepsy. Epilepsia 48 (suppl. 2), 65–74 (2007).
Prince, D.A., Parada, I. & Graber, K. in Jasper's Basic Mechanisms of the Epilepsies [Internet] 4th edn. (eds. Noebels, J.L. et al.) Ch. 24, 315–321 (National Center for Biotechnology Information, Bethesda, Maryland, 2012).
Heinzen, E.L. et al. ATP1A3 Working Group. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol. 13, 503–514 (2014).
Vaillend, C., Mason, S.E., Cuttle, M.F. & Alger, B.E. Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region. J. Neurophysiol. 88, 2963–2978 (2002).
Guerrini, R. & Dobyns, W.B. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol. 13, 710–726 (2014).
Mirzaa, G.M. & Poduri, A. Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology. Am. J. Med. Genet. C. Semin. Med. Genet. 166C, 156–172 (2014).
Berdichevsky, Y. et al. PI3K-Akt signaling activates mTOR-mediated epileptogenesis in organotypic hippocampal culture model of post-traumatic epilepsy. J. Neurosci. 33, 9056–9067 (2013).
Lasarge, C.L. & Danzer, S.C. Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front. Mol. Neurosci. 7, 18 (2014).
Wong, M. A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev. Neurother. 13, 657–669 (2013).
Buckmaster, P.S. & Lew, F.H. Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. J. Neurosci. 31, 2337–2347 (2011).
Gardiner, J. & Marc, J. Disruption of normal cytoskeletal dynamics may play a key role in the pathogenesis of epilepsy. Neuroscientist 16, 28–39 (2010).
McNamara, J.O., Huang, Y.Z. & Leonard, A.S. Molecular signaling mechanisms underlying epileptogenesis. Sci. STKE 2006, re12 (2006).
Fernández, E., Rajan, N. & Bagni, C. The FMRP regulon: from targets to disease convergence. Front. Neurosci. 7, 191 (2013).
Na, E.S., Nelson, E.D., Kavalali, E.T. & Monteggia, L.M. The impact of MeCP2 loss- or gain-of-function on synaptic plasticity. Neuropsychopharmacology 38, 212–219 (2013).
Marsh, E.D. & Golden, J.A. in Jasper's Basic Mechanisms of the Epilepsies [Internet] 4th edn. (eds. Noebels, J.L. et al.) Ch. 63, 813–823 (National Center for Biotechnology Information, Bethesda, Maryland, 2012).
Kato, M. & Dobyns, W.B. X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, interneuronopathy. J. Child Neurol. 20, 392–397 (2005).
Southwell, D.G. et al. Interneurons from embryonic development to cell-based therapy. Science 344, 1240622 (2014).
O'Leary, T. & Wyllie, D.J. Neuronal homeostasis: time for a change? J. Physiol. (Lond.) 589, 4811–4826 (2011).
Frey, L.C. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 44 (suppl. 10), 11–17 (2003).
Volman, V., Bazhenov, M. & Sejnowski, T.J. Pattern of trauma determines the threshold for epileptic activity in a model of cortical deafferentation. Proc. Natl. Acad. Sci. USA 108, 15402–15407 (2011).
Turrigiano, G.G., Leslie, K.R., Desai, N.S., Rutherford, L.C. & Nelson, S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391, 892–896 (1998).
Carvill, G.L. et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat. Genet. 45, 1073–1076 (2013).
Ogiwara, I. et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 27, 5903–5914 (2007).
Liu, Y. et al. Dravet syndrome patient–derived neurons suggest a novel epilepsy mechanism. Ann. Neurol. 74, 128–139 (2013).
Girard, J.M., Turnbull, J., Ramachandran, N. & Minassian, B.A. Progressive myoclonus epilepsy. Handb. Clin. Neurol. 113, 1731–1736 (2013).
Chabrol, B., Caillaud, C. & Minassian, B. Neuronal ceroid lipofuscinoses. Handb. Clin. Neurol. 113, 1701–1706 (2013).
Acknowledgements
This work was funded by US National Institutes of Health grants NS034700 and NS040109.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Staley, K. Molecular mechanisms of epilepsy. Nat Neurosci 18, 367–372 (2015). https://doi.org/10.1038/nn.3947
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3947
This article is cited by
-
Knockdown of SIK3 in the CA1 Region can Reduce Seizure Susceptibility in Mice by Inhibiting Decreases in GABAAR α1 Expression
Molecular Neurobiology (2024)
-
Biomolecular mechanisms of epileptic seizures and epilepsy: a review
Acta Epileptologica (2023)
-
Wake slow waves in focal human epilepsy impact network activity and cognition
Nature Communications (2023)
-
Ictogenesis proceeds through discrete phases in hippocampal CA1 seizures in mice
Nature Communications (2023)
-
Activation of TLR7-mediated autophagy increases epileptic susceptibility via reduced KIF5A-dependent GABAA receptor transport in a murine model
Experimental & Molecular Medicine (2023)